Quantiscope PBC leverages deep learning and image-based innovation to pioneer PhenotypIQ® digital twin technology, transforming the sustainability, safety, and efficacy of drug discovery, bio-processing, and bio-manufacturing.
Quantiscope is an AI-driven public benefit corporation launched from the Broad Institute of Harvard/MIT, and currently housed in the Altitude Lab incubator in Salt Lake City. Our automated analysis platform transforms microscopic images into rich phenotypic data for decision making in drug discovery and bio-manufacturing applications. Our platform is suitable for high-content image analysis of fluorescent and brightfield images, and we are innovating in sub-cellular analysis with applications such as quality control of nanoparticle vaccines and gene therapies.
Company Details
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.imaging.bio/
Quantiscope® Questions
Quantiscope®'s website is https://www.imaging.bio/
Quantiscope®'s LinkedIn profile is https://www.linkedin.com/company/quantiscope
Quantiscope®'s industry is
Biotechnology Research
Quantiscope®'s top competitors are
Sensable,
Mycofog®,
Rockridge® B Corp Law,
Peel Therapeutics,
Anziva Pharmaceuticals,
Sunrun,
Coast 2 Coast Test Prep,
Sethera Therapeutics,
Translational Epilepsy Network,
Quantiscope, Llc.
Quantiscope®'s categories are Biotechnology Research
Quantiscope®'s founding year is 2022
